CSHL scientists identify new drug target against virulent type of breast cancer (27 Aug 2008) Enzyme target, Brk, is shown to be an accelerator of HER2-positive tumors to test." The team checked breast cancertissue from more than two hundred...
Tumor cells in a particular subset of breast cancer patients churn out too... focused on Brk, which they knew to be over-produced in many other types of cancer...
Affimed validates antibody target for cancer metastasis (14 May 2008) cancertissue. In the present study, it was challenged in a metastatic cancer... has strongly validated a target for cancer metastases amenable to the development... laminin receptor precursor and/ or its receptor, is overexpressed in cancer cell...
ThromboGenics and BioInvent Publicate Data on a Novel Class of Angiogenesis Inhibitors (05 Nov 2007) Novel anti-PlGF antibody, TB-403, being developed by ThromboGenics and BioInvent for only in the cancertissue. ThromboGenics and BioInvent have made the decision... potential of anti-PlGF agents to treat cancer based on research performed... factor) can inhibit cancer tumour growth and the development of metastases...
DakoCytomation Offers New Diagnostic Option for Breast Cancer Patients in Europe (01 Jun 2004) for use as an aid in identifying European breast cancer patients eligible... cancer. HER2 FISH pharmDx(TM) is a fluorescence in situ hybridization (FISH) assay designed to quantitatively determine HER2 gene amplification in breast cancer...
Top